SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024997
Filing Date
2022-11-14
Accepted
2022-11-14 16:12:28
Documents
70
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q impl-20220930.htm   iXBRL 10-Q 3237937
2 EX-31.1 impl-ex31_1.htm EX-31.1 21040
3 EX-31.2 impl-ex31_2.htm EX-31.2 20761
4 EX-32.1 impl-ex32_1.htm EX-32.1 10173
5 EX-32.2 impl-ex32_2.htm EX-32.2 10221
  Complete submission text file 0000950170-22-024997.txt   10106327

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT impl-20220930.xsd EX-101.SCH 69696
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT impl-20220930_pre.xml EX-101.PRE 411126
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT impl-20220930_lab.xml EX-101.LAB 568424
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT impl-20220930_cal.xml EX-101.CAL 46724
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT impl-20220930_def.xml EX-101.DEF 233762
64 EXTRACTED XBRL INSTANCE DOCUMENT impl-20220930_htm.xml XML 1634059
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: 10-Q | Act: 34 | File No.: 001-40353 | Film No.: 221385391
SIC: 2834 Pharmaceutical Preparations